Find Academic Supervisors

Adeola AdebisiView profile

Senior Lecturer

• Pharmaceutical Science
• Drug Delivery Systems
• Nanotechnology in Drug Delivery
• +3 more

Dr. Adeola Adebisi is a Senior Lecturer in the Department of Pharmacy at the University of Huddersfield, UK. Her research focuses on pharmaceutical formulation science, with expertise in drug delivery systems, nanotechnology, gastroretentive systems, and polymer engineering. She holds a PhD from the University of Huddersfield (2014), supervised by Prof. Barbara Conway, specializing in gastro-retentive systems targeting Helicobacter pylori infections. Education: BPharm (First Class) - University of Ibadan, Nigeria (2007) MSc Pharmaceutical Science (Distinction) - Aston University, UK (2009) PhD Pharmaceutical Science - University of Huddersfield, UK (2014) Research Interests: Development of nanotechnology-based drug delivery systems Formulation of controlled release systems Modification of natural polymers for drug delivery Optimization of solid dispersions and crystalline systems Pharmaceutical applications of African starches and polysaccharides Recent work emphasizes nasal drug delivery via chitosan/PLGA nanoparticles, electrospun nanofiber applications, and freeze-dried crystalline dispersions. Her studies consistently address dissolution enhancement and targeted drug delivery mechanisms. She is affiliated with the Pharmaceutical Policy and Practice Research Centre and Pharmaceutics & Drug Delivery Centre at the University of Huddersfield. Supervision: Accepting PhD students in drug delivery and formulation science.

Matthew LamView profile

Lecturer

• Pharmaceutical Formulation
• Drug Delivery Systems
• Bioavailability Enhancement
• +3 more

Dr. Matthew Lam is Lecturer in Pharmaceutics at London Metropolitan University and inventor of Liqui-Pellet technology. His research focuses on next-generation drug delivery platforms enhancing bioavailability of poorly soluble drugs through innovative formulation strategies. With industry experience from Imperial College Healthcare NHS Trust, he bridges clinical insights with pharmaceutical development. His patented Liqui-Pellet system enables cost-effective, sustainable manufacturing while addressing dysphagia challenges in geriatric care.

• Materials Chemistry
• Computational Chemistry
• Pharmaceutical Science
• +4 more

Dr Richard Singer is an Associate Professor in Physical Chemistry at the Department of Chemical and Pharmaceutical Sciences, School of Life Sciences, Pharmacy and Chemistry, Kingston University. He has been a Senior Lecturer since 1992 and later became Head of Department, overseeing the design of modern STEM laboratories. Education: BSc (1st Class) and PhD in Chemistry from the University of East Anglia Research Focus: Materials chemistry, computational chemistry, and pharmaceutical science His research explores organic/inorganic hybrid materials for electronic applications like solar cells and electronic devices, with recent work on muon spin resonance studies of membrane-drug interactions. Collaborations include Dr Gemma Shearman and Dr Joseph Bear. Key publication trends span materials and environmental chemistry (2013-2023), organic synthesis (2018-2021), and physical chemistry (1995). Scientific Awards: BP Venture-Research Fellowship at University of Cambridge As Head of Department, he has led laboratory modernization projects, integrating electronic lab books and digital assessment tools. His teaching emphasizes kinetics, surface chemistry, and computational methods across MSc and BSc programs.

• Fatty Liver
• Stem Cells
• Hepatocytes
• +4 more

Joost Boeckmans is a postdoctoral researcher at the Faculty of Medicine and Pharmacy , Vrije Universiteit Brussel, Belgium. His work focuses on stem cell-based in vitro models for studying liver diseases, drug responses, and toxicology. He is affiliated with the In Vitro Toxicology and Dermato-Cosmetology department and holds a Researcher title. Education: PhD in Pharmaceutical and Pharmacological Sciences (2020), Master's in Pharmaceutical Sciences (2016, 2018), Master's in Pharmaceutical Sciences (2024). Joost's research spans non-alcoholic fatty liver disease (NAFLD/NASH) , genetic predisposition in drug response , in vitro toxicology , and adverse outcome pathways . His work integrates human stem cells , polygenic risk scores , and thyroid hormone signaling to develop drug testing platforms. Recent publications (2025) explore MASLD/ALD cirrhosis outcomes , PNPLA3 I148M mutation in liver injury, and anti-MAFLD drug development . Key article trends include genetic mediators (ANGPTL4, PDK4, PLIN2) , in vitro model optimization , and cross-disease comparisons (ALD vs. MASLD) . His scientific awards include: Colgate-Palmolive postdoctoral fellowship (2023) National Award of the Belgian Society of Pharmaceutical Sciences (2021) Poster prizes at Global NASH Congress (2019) and BelTox/IC-3Rs/INVITROM Joint Symposium (2019) Joost collaborates on projects like FWOSB134 (anti-MAFLD drugs) and AIIFUND101 (PRS-HFC for drug responses). He has presented at conferences in 2022-2024 , including talks on anti-MASH drug response and liver steatosis AOP networks .

• Pharmaceutical technology
• Drug formulation development
• Bioavailability enhancement
• +4 more

Prof. David Vetchý serves as Dean of the Faculty of Pharmacy at Masaryk University in Brno, Czech Republic. He is a Professor in the Department of Pharmaceutical Technology with extensive expertise in pharmaceutical formulation and drug delivery systems. His leadership extends to multiple institutional committees including the Dean's College, Rector's Board, and Scientific Council of the Faculty of Pharmacy. Prof. Vetchý's research focuses on pharmaceutical technology, particularly in drug formulation development, bioavailability enhancement of poorly soluble drugs, and quality control of pharmaceutical products. His work encompasses solid dosage forms, self-emulsifying drug delivery systems, enteric coatings, and analytical methods for drug characterization. He has made significant contributions to understanding drug-polymer interactions, dissolution testing methodologies, and developing novel detection systems for chemical warfare agents. His extensive publication record demonstrates consistent research activity with over 130 publications spanning more than a decade. Recent work shows a strong focus on bioequivalence studies, novel drug delivery systems, and pharmaceutical education. His collaborative research addresses both fundamental pharmaceutical science questions and practical drug development challenges across multiple therapeutic areas. Dean's College, Faculty of Pharmacy Rector's Board, Masaryk University Industry Council for Safety and quality of medicines Extended Rector's Board, Masaryk University HR Award Steering Committee, Faculty of Pharmacy Scientific Council, Faculty of Pharmacy and Central European Institute of Technology Prof. Vetchý actively supervises students and has contributed significantly to pharmaceutical education at Masaryk University. His research has practical applications in drug development and quality control, with several patented technologies related to drug delivery systems and detection methods. His work spans from fundamental pharmaceutical science to translational research with clinical applications in areas including asthma treatment, addiction therapy, and chemical detection systems.

• Biotechnology innovation management
• Pharmaceutical drug development
• Drug pricing and affordability
• +2 more

Professor Jan Rosier , Élan Full Professor of the Business of Biotechnology at University College Dublin's School of Biomolecular and Biomedical Science, combines pharmaceutical science expertise with business strategy. Holding doctorates from Ghent University and Cranfield School of Management, he previously served as VP at Johnson & Johnson and CEO of FORMAC Pharmaceuticals NV. Current affiliations: University College Dublin, Trinity College Dublin (Adjunct), University of Turin (Visiting) PhD in Pharmaceutical Sciences & PhD in Management Research Interests: Focus on biotechnology innovation management, drug pricing economics, and formulation technologies for HIV treatments. His work explores absorptive capacity in R&D and alternative mechanisms for drug affordability. Teaching: Coordinates modules in biotech economics, innovation strategy, and pharmaceutical management at UCD. Advocates student interaction and class discussion pedagogy. Scientific Awards: Johnson & Johnson Leadership Award for PREZISTA development Johnson & Leadership Award for INTELENCE development Fulbright Scholarship (Harvard University) NATO Research Fellowship (MIT) Professional Memberships: Advisory Board member of Incentives for Global Health's Health Impact Fund, American Association of Pharmaceutical Scientists.

ROSSI AlessandraView profile

Associate Professor

• Drug Polymorphism
• Pharmaceutical Excipients
• Controlled Drug Release
• +3 more

Alessandra Rossi is an Associate Professor at the Department of Food and Pharmaceutical Sciences, University of Parma. She coordinates the department's International Mobility Commission and contributes to the university's Internationalization Working Group. Her academic journey includes a PhD at the University of Strathclyde and postdoctoral work at Heriot-Watt University. PhD in Pure and Applied Chemistry (1998, University of Strathclyde) Graduated in Chemistry (1993, University of Pavia) Her research focuses on pharmaceutical technologies for controlled drug release, including hydrophilic matrices, nasal/pulmonary powders, and nano-microparticulate systems. She leads the COST Action SimInhale's Working Group 1 on particle engineering for inhaled medicines. Key trends in her publications include 3D-printed drug forms , phytoextract microencapsulation , nano-inhalation systems , and biopharmaceutical modeling . Her work bridges formulation science with clinical applications. Erasmus Scholarship (1993) Novartis Postdoctoral Fellowship (1998) She mentors students through teaching roles in Pharmaceutical Legislation, Galenic Preparations, and bibliographic research, with ongoing involvement in multidisciplinary pharmaceutical projects.

• Pharmaceutical Sciences
• Drug Delivery
• Transdermal Drug Delivery
• +4 more

Dr. Radeyah Ali serves as a Teaching Fellow at Aston University within the College of Health and Life Sciences, specifically affiliated with the Aston School of Pharmacy in Birmingham, United Kingdom. Her academic role focuses on pharmaceutical education and research in advanced drug delivery systems, particularly microneedle-based transdermal technologies. Her research portfolio centers on Microneedle Technology and Transdermal Drug Delivery , with significant contributions to Polymeric Materials engineering, Quality by Design methodologies, and Scanning Electron Microscopy characterization. She specializes in developing polymeric and metal microneedles for enhanced drug release profiles, vaccine delivery (including BCG applications), and peptide/protein therapeutics. Her work bridges pharmaceutical sciences with materials engineering to solve transdermal delivery challenges. Analysis of her five publications (2019-2021) reveals a cohesive research trajectory focused on microneedle innovation. Key trends include materials science optimization for metal/polymeric microneedles, quality-by-design implementation in fabrication processes, and applications for vaccines, antihistamines, and solid oral dosage forms. Her highly cited review article demonstrates expertise in pharmaceutical manufacturing technologies, while experimental studies showcase methodological rigor in drug release characterization and electron microscopy analysis. No scientific awards, fellowships, or medals are documented in available records. Academic advising activities, grant funding details, and laboratory/team compositions remain undisclosed in the provided information.

Denis RingView profile

Lecturer

• Pharmaceutical Manufacturing
• Process Optimization
• Powder Technology
• +7 more

Dr. Denis Ring is a Lecturer in Process & Chemical Engineering at University College Cork (UCC), with extensive experience spanning over three decades in academia and industry. He holds a PhD (2012) and multiple postgraduate teaching qualifications from UCC, alongside earlier degrees from the University of Strathclyde and Cork Institute of Technology. His roles include teaching core courses like Pharmaceutical Engineering and Process Design, as well as supervising student projects and contributing to laboratory resources. Dr. Ring is a Fellow of the Institution of Chemical Engineers (FIChemE) and a member of Engineers Ireland and ISPE. His research focuses on pharmaceutical process optimization, particularly in granulation and modified-release drug production, alongside interests in Pharma 4.0, powder technology, and sustainable manufacturing. He actively promotes engineering education through initiatives like the KNEX Challenge and has organized international conferences such as the 3rd International Symposium for Engineering Education (ISEE2010), emphasizing sustainability in engineering curricula. Dr. Ring collaborates with industry partners to bridge academic and industrial practices, emphasizing practical applications of process design and safety. His publications span topics including buffer management in biopharmaceuticals, Industry 4.0's role in pharmaceutical manufacturing, and the integration of sustainability into engineering education. He has supervised numerous student projects, contributing to the development of future engineers capable of addressing global challenges through sustainable and innovative solutions.

• Pharmaceutical Chemistry
• Tablet Manufacturing
• Powder Flow Analysis
• +3 more

Osmo Antikainen is a University researcher and visiting researcher at the Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki. He serves as a Supervisor in the Doctoral Programme in Drug Research. His research focuses on pharmaceutical chemistry and technology, particularly tablet manufacturing, powder flow properties, and AI-driven quality control. Recent work includes AI frameworks for tablet compression and image-based analysis of powder dynamics. Antikainen has supervised doctoral theses on topics like pharmaceutical powder behavior and formulation stability. He collaborates with organizations such as Care4living Oy, DAIN Studios Oy, and Business Finland on projects like NIR-Based PAT Applications and LifeFactFuture . His publications (65 total) and projects (3 active/inactive) span 2000–2025, with a focus on process optimization and material interactions in pharmaceutical manufacturing.

Karl VorländerView profile

Researcher

• Pharmaceutical Technology
• Biotechnology
• Particle Technology
• +3 more

Karl Vorländer is a Researcher at the Institute for Particle Technology , part of the Faculty of Mechanical Engineering at Technische Universität Braunschweig. He has been affiliated with the university since 2013, focusing on pharmaceutical technology and bioprocessing. Education: Biotechnology degree (2013–2016) at TU Braunschweig; Master’s and Bachelor’s theses centered on microbial preservation and process engineering. His research explores the mechanical impacts on microbial viability during pharmaceutical manufacturing processes like fluidized bed granulation, spray drying, and tableting. This work bridges biotechnology with particle technology to optimize probiotic tablet production. Karl’s publications (2020–2025) analyze compression dynamics, protectants, and carrier materials in tablet production, highlighting interdisciplinary applications of biotechnology, mechanical engineering, and pharmaceutical science. He is based at the Pharmazeutische Technologie lab (Franz-Liszt Str. 35A, Room 262) and contributes to advancing research in bioprocessing equipment and production chain optimization.

Olle GyllenhaalView profile

Associate Professor

• Analytical Chemistry
• Pharmaceutical Chemistry
• Medicinal Chemistry
• +5 more

Olle Gyllenhaal is an Associate Professor at the Department of Medicinal Chemistry, Uppsala University, specializing in Analytical Pharmaceutical Chemistry. He focuses on supercritical fluid chromatography (SFC), enantiomer separation, and the application of chemometrics for optimizing analytical methods. His work includes drug purity analysis, formulation assays, and studying interactions between compounds like aliphatic amines and carbon dioxide. His recent publications emphasize advancements in SFC techniques for pharmaceuticals, including the analysis of metoprolol, clevidipine, and other chiral compounds. He investigates peak compression effects, chiral selector additives, and direct injection methods for aqueous samples. Currently, no scientific awards or specific student advisement records are disclosed in the provided texts. His research contributes to improving analytical methodologies in medicinal chemistry.

Cedric BriensView profile

Professor

• Fluidization and Particulate Operations
• Biomass Conversion Technologies
• Heavy Oil Processing
• +3 more

Cedric Briens is a Professor and NSERC/Syncrude Industrial Research Chair in Fluid Coking Technologies at the Department of Chemical and Biochemical Engineering, Faculty of Engineering, Western University. He founded and directs the Institute for Chemical and Fuels from Alternative Resources (ICFAR), focusing on converting biomass and fossil fuels into valuable products through fluidization and particulate operations. His work spans industrial applications with Syncrude Canada, ExxonMobil, Agri-Therm, and Imperial Oil. Diplôme d'Ingénieur (ENSIC) 1975 Ph.D. (Western) 1980 His research includes: Commercial-scale fluid coking processes Mobile pyrolyzers for agricultural/forestry waste Upgrading pyrolytic bio-oil Advanced multiphase reactors for thermal/catalytic cracking Recent publications focus on biochar granulation, acoustic monitoring of powder mixing, and pyrolysis reactor design. His work bridges chemical engineering fundamentals with industrial implementation across energy, agriculture, and pharmaceutical fields. Students in his group include Shahzad Barghi, Amarjeet Bassi, Franco Berruti, Paul Charpentier, and others. Cedric has over 25 years of combined academic and industrial experience.

Jonathan SevilleView profile

Visiting Professor

• Chemical Engineering
• Powder Technology
• Fluidization
• +4 more

Professor Jonathan Seville is a Visiting Professor of Chemical Engineering at the University of Surrey, affiliated with the School of Chemistry and Chemical Engineering. He has held significant leadership roles, including President of the Institution of Chemical Engineers (2016–2017) and Executive Dean of the Faculty of Engineering and Physical Sciences at the University of Surrey (2011–2016). He earned degrees in Chemical Engineering from the Universities of Cambridge and Surrey. His career includes visiting appointments at the University of British Columbia and the Technical University of Denmark. Seville’s research focuses on powder technology, fluidization, pharmaceutical manufacturing, and energy systems. He pioneered the use of positron-emitting radioactive tracers in engineering studies, co-founding the Positron Imaging Centre. His work in biomass conversion and solar power led to the creation of Recycling Technologies, a successful spin-out company. He has also contributed to advancements in granulation processes, fluidized bed dynamics, and drug delivery systems. Key awards include the Queen’s Anniversary Prize (2011) for the Formulation Engineering Research Centre and fellowships from the Royal Academy of Engineering and the Institution of Chemical Engineers. His publications span over three decades, addressing topics such as particle motion tracking, energy-efficient processes, and pharmaceutical formulation. Collaborations with industries like Unilever, Procter & Gamble, and Siemens highlight his translational research impact. Seville has advised on numerous grants and industrial projects, emphasizing sustainable technologies and process optimization. His leadership roles in academic and professional bodies, including the Engineering Council’s Registration Standards Committee, underscore his influence in shaping engineering education and practice.

Rajesh DaveView profile

Professor

• Pharmaceutical Process Engineering
• Powder Technology
• Drug Delivery Systems
• +5 more

Rajesh Dave is a Distinguished Professor in the Department of Chemical & Materials Engineering at the New Jersey Institute of Technology (NJIT). He holds a B.S. from the Indian Institute of Technology Bombay and M.S./Ph.D. degrees from Utah State University, all in Mechanical Engineering. His research focuses on pharmaceutical process engineering, powder technology, and material science, with applications in drug delivery systems and manufacturing optimization. He has pioneered dry coating techniques to enhance powder blend processability and employs machine learning for predictive modeling in pharmaceutical processes. Education: Ph.D., Mechanical Engineering, Utah State University (1983) M.S., Mechanical Engineering, Utah State University (1981) B.S., Mechanical Engineering, Indian Institute of Technology Bombay (1978) Research interests include powder compaction mechanics, surface engineering of pharmaceutical particles, and scalable manufacturing solutions for poorly soluble drugs. His work integrates experimental and computational methods to address challenges in drug formulation, process analytical technology (PAT), and quality-by-design (QbD) frameworks. Recent projects emphasize enhancing drug dissolution rates via nanoparticle engineering and optimizing 3D-printed dosage forms. Scientific Awards: 2022 AIChE PD2M Award for QbD Contributions 2021 Fellow of the National Academy of Inventors (NAI) His research has led to innovations in engineered excipients, continuous manufacturing systems, and predictive models for powder flowability. Collaborative efforts with industry partners focus on translating lab-scale discoveries into industrial applications. He maintains an active laboratory and advises on grants related to pharmaceutical manufacturing excellence.